Critic at Large

» techniques, publishing and regulation

Most Recent

image: Opinion: Why I Published in a Predatory Journal

Opinion: Why I Published in a Predatory Journal

By | April 6, 2017

Our totally bogus case report swiftly passed muster, with only minor revisions requested.

10 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

image: Getting Animal Research Right

Getting Animal Research Right

By | March 1, 2016

Regulatory and compliance expectations for animal-based research are demanding, while public and political scrutiny of animal research is rising.

2 Comments

image: Defending Against Plagiarism

Defending Against Plagiarism

By | June 1, 2013

Publishers need to be proactive about detecting and deterring copied text.

5 Comments

image: DIYbio: Low Risk, High Potential

DIYbio: Low Risk, High Potential

By | March 1, 2013

Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.

5 Comments

image: Regulating Amateurs

Regulating Amateurs

By | March 1, 2013

How should the government ensure the safety and responsibility of do-it-yourself biologists?

2 Comments

image: Bring On the Transparency Index

Bring On the Transparency Index

By | August 1, 2012

Grading journals on how well they share information with readers will help deliver accountability to an industry that often lacks it.

6 Comments

image: Predatory Publishing

Predatory Publishing

By | August 1, 2012

Overzealous open-access advocates are creating an exploitative environment, threatening the credibility of scholarly publishing.

32 Comments

image: All’s Not Fair in Science and Publishing

All’s Not Fair in Science and Publishing

By | July 1, 2012

False credit for scientific discoveries threatens the success and pace of research.

72 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Athletes’ Microbiomes Differ from Nonathletes
  3. Gut Feeling
    Daily News Gut Feeling

    Sensory cells of the mouse intestine let the brain know if certain compounds are present by speaking directly to gut neurons via serotonin.

  4. Immune Cells Deliver Cancer Drugs to the Brain
AAAS